
Kevin S. Orwig
Examiner (ID: 15505, Phone: (571)270-5869 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 3991, 1658, 1611 |
| Total Applications | 910 |
| Issued Applications | 256 |
| Pending Applications | 48 |
| Abandoned Applications | 609 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17602900
[patent_doc_number] => 11331369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Endoparasitic depsipeptides
[patent_app_type] => utility
[patent_app_number] => 16/652136
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53038
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652136 | Endoparasitic depsipeptides | Nov 27, 2018 | Issued |
Array
(
[id] => 19058431
[patent_doc_number] => 11937618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Method for providing a proteinaceous composition without pH adjustment
[patent_app_type] => utility
[patent_app_number] => 16/198851
[patent_app_country] => US
[patent_app_date] => 2018-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2654
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/198851 | Method for providing a proteinaceous composition without pH adjustment | Nov 21, 2018 | Issued |
Array
(
[id] => 16435710
[patent_doc_number] => 20200353035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => TREATMENT OF PARASITIC INFECTIONS OF FISH SURFACES
[patent_app_type] => utility
[patent_app_number] => 16/764437
[patent_app_country] => US
[patent_app_date] => 2018-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764437 | TREATMENT OF PARASITIC INFECTIONS OF FISH SURFACES | Nov 19, 2018 | Abandoned |
Array
(
[id] => 18152074
[patent_doc_number] => 11565024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Lysostaphin containing synthetic hydrogel carriers for bone repair
[patent_app_type] => utility
[patent_app_number] => 16/191685
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 126
[patent_no_of_words] => 8700
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191685 | Lysostaphin containing synthetic hydrogel carriers for bone repair | Nov 14, 2018 | Issued |
Array
(
[id] => 14016191
[patent_doc_number] => 20190070089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Stable Silk Protein Fragment Compositions
[patent_app_type] => utility
[patent_app_number] => 16/184098
[patent_app_country] => US
[patent_app_date] => 2018-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16184098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/184098 | Stable silk fibroin based pharmaceutical formulations | Nov 7, 2018 | Issued |
Array
(
[id] => 17975527
[patent_doc_number] => 11492375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Cyclic peptide immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/753666
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41146
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 492
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753666 | Cyclic peptide immunomodulators | Oct 1, 2018 | Issued |
Array
(
[id] => 14403493
[patent_doc_number] => 20190167590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making Same
[patent_app_type] => utility
[patent_app_number] => 16/142639
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142639
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142639 | Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making Same | Sep 25, 2018 | Abandoned |
Array
(
[id] => 16252160
[patent_doc_number] => 20200261534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => NEW TREATMENTS OF MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 16/651983
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651983 | NEW TREATMENTS OF MULTIPLE MYELOMA | Sep 9, 2018 | Abandoned |
Array
(
[id] => 16268822
[patent_doc_number] => 20200270309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/646576
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646576 | MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF | Sep 6, 2018 | Abandoned |
| 16/120549 | GROWTH DIFFERENTIATION FACTOR 11 (GDF-11) FOR TREATMENT OF DIASTOLIC HEART FAILURE | Sep 3, 2018 | Pending |
Array
(
[id] => 16139113
[patent_doc_number] => 10702610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors
[patent_app_type] => utility
[patent_app_number] => 16/116045
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4346
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116045 | Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors | Aug 28, 2018 | Issued |
Array
(
[id] => 16806149
[patent_doc_number] => 20210128702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/635714
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635714 | USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS | Aug 12, 2018 | Abandoned |
Array
(
[id] => 16376335
[patent_doc_number] => 20200325177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/635070
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635070 | METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF | Jul 30, 2018 | Abandoned |
Array
(
[id] => 13549135
[patent_doc_number] => 20180326115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => FIBRINOGEN-BASED TISSUE ADHESIVE PATCHES
[patent_app_type] => utility
[patent_app_number] => 16/041903
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041903
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/041903 | Fibrinogen-based tissue adhesive patches | Jul 22, 2018 | Issued |
Array
(
[id] => 13533773
[patent_doc_number] => 20180318429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => USE OF HYDROPHOBIC ORGANIC ACIDS TO INCREASE HYDROPHOBICITY OF PROTEINS AND PROTEIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/032952
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16032952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/032952 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | Jul 10, 2018 | Issued |
Array
(
[id] => 13519243
[patent_doc_number] => 20180311164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => TREATING FUNGAL INFECTION OF THE NAIL UNIT
[patent_app_type] => utility
[patent_app_number] => 16/025979
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025979 | TREATING FUNGAL INFECTION OF THE NAIL UNIT | Jul 1, 2018 | Abandoned |
Array
(
[id] => 15483209
[patent_doc_number] => 10556937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/010962
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18376
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010962 | Methods for the production of a cosmetic composition comprising leukolectin and uses thereof | Jun 17, 2018 | Issued |
Array
(
[id] => 15740561
[patent_doc_number] => 20200109168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => MACROCYCLIC PEPTIDES AND DERIVATIVES THEREOF WITH OPIOID ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/622749
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622749 | Macrocyclic peptides and derivatives thereof with opioid activity | Jun 14, 2018 | Issued |
Array
(
[id] => 13424771
[patent_doc_number] => 20180263928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => AMANTADINE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/985300
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985300 | AMANTADINE COMPOSITIONS AND METHODS OF USE | May 20, 2018 | Abandoned |
Array
(
[id] => 13729357
[patent_doc_number] => 20180369146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
[patent_app_type] => utility
[patent_app_number] => 15/982287
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982287
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982287 | METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT | May 16, 2018 | Abandoned |